Profound Medical to Participate in the Stifel 2024 Healthcare Conference
12 nov. 2024 08h00 HE
|
Profound Medical Corp.
TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Third Quarter 2024 Financial Results
07 nov. 2024 16h05 HE
|
Profound Medical Corp.
TORONTO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
04 nov. 2024 06h55 HE
|
Profound Medical Corp.
– TULSA to stand above all other covered prostate disease treatment modalities at Urology Level 7 reimbursement – – First-time CPT® code reimbursement for TULSA to be effective...
Profound Medical Appoints Tom Tamberrino as Chief Commercial Officer
16 oct. 2024 16h15 HE
|
Profound Medical Corp.
– Mr. Tamberrino and Profound’s CEO, Arun Menawat, previously worked together at NOVADAQ before it was acquired by Stryker in 2017 – – Appointment comes as Profound continues to make final...
Profound Medical Announces Second Quarter 2024 Financial Results
08 août 2024 16h05 HE
|
Profound Medical Corp.
TORONTO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
18 juil. 2024 16h30 HE
|
Profound Medical Corp.
TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
11 juil. 2024 07h00 HE
|
Profound Medical Corp.
TORONTO, July 11, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
The Bengtson Center Now Offers Profound® for Youthful-Looking Skin
11 sept. 2019 11h05 HE
|
The Bengtson Center for Aesthetics and Plastic Surgery
GRAND RAPIDS, Mich., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Patients who frequent the Bengtson Center will not be surprised to learn that Dr. Brad Bengtson and Dr. David Alfonso have added yet another...
Deep Blue Med Spa Announces New Profound Procedure to Treat Wrinkles and Rejuvenate Jawline
13 déc. 2018 09h00 HE
|
Long Island Plastic Surgical Group, PC
LONG ISLAND, NY, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Deep Blue Med Spa, overseen by the plastic surgeons at Long Island Plastic Surgical Group, is pleased to announce the addition of Profound, a...